Sequenom Inc. (SQNM)
-NasdaqGS | Prev Close: | 4.22 |
|---|
| Open: | N/A |
|---|
| Bid: | 4.07 x 100 |
|---|
| Ask: | 5.25 x 200 |
|---|
| 1y Target Est: | 7.21 |
|---|
| Beta: | 0.76 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 2.65 - 5.36 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 2,340,720 |
|---|
| Market Cap: | 485.94M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Here's What This Top-Earning Billionaire Has Been Buyingat Motley Fool(Wed, Jun 19)
- SEQUENOM INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Sun, Jun 16)
- Is Sequenom Stock Destined for Greatness?at Motley Fool(Fri, Jun 14)
- SEQUENOM INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of SecuriEDGAR Online(Thu, Jun 13)
- Here's What This $4 Billion Winning Hedge Fund Company Has Bought and Soldat Motley Fool(Wed, Jun 12)
- Sequenom CMM Opens New CLIA Lab Facility In North CarolinaPR Newswire(Wed, Jun 12)
- Sequenom: Deciphering The Business Modelat Seeking Alpha(Tue, Jun 11)
- How to Find the Right Investment Opportunities by Using Beta Scoresat Motley Fool(Mon, Jun 10)
- Sequenom: Disruptive Innovation Is Driving Investment In NIPTat Seeking Alpha(Mon, Jun 3)
- Sequenom, Inc. [SQNM] to Ring The NASDAQ Stock Market Opening BellGlobeNewswire(Fri, May 31)
- Sequenom announces licensing, marketing agreements with Laboratoire Cerbaat theflyonthewall.com(Thu, May 30)
- Sequenom Announces License And Marketing Agreements With Laboratoire Cerba In FrancePR Newswire(Thu, May 30)
- Sequenom Announces Participation At The Jefferies Global Healthcare ConferencePR Newswire(Tue, May 28)
- Correction: Sequenom-Mover storyAP(Fri, May 24)
- Commit To Purchase Sequenom At $2.50, Earn 24.8%at TheStreet(Fri, May 24)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 4.29 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.81 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.22 |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | -0.21 |
|---|
Business Summary
Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
View More